Davita Inc. Stock
Price
Target price
€120.00
€120.00
1.560%
1.85
1.560%
€124.89
19.04.24 / Tradegate
WKN: 897914 / Symbol: DVA / Name: DaVita HHlthcr / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Davita Inc. Stock
There is an upward development for Davita Inc. compared to yesterday, with an increase of €1.85 (1.560%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Davita Inc. stock is not clear.
As a result the target price of 124 € shows a slightly positive potential of 3.33% compared to the current price of 120.0 € for Davita Inc..
For the coming years our community has positive and negative things to say abot the Davita Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Davita Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Davita Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 1.560% | -2.161% | -5.734% | 57.192% | 27.092% | 30.406% | 162.985% |
| Amn Healthcare Svs | - | -0.952% | -12.605% | -33.758% | -22.388% | -17.460% | 23.928% |
| Ensign Group Inc. | -0.910% | 1.818% | -1.754% | - | 8.738% | - | - |
| Chemed Corp. | -0.890% | -1.754% | -7.438% | 12.000% | 7.692% | 38.614% | 100.429% |
Comments
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at UBS Group AG from $113.00 to $134.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target lowered by analysts at UBS Group AG from $142.00 to $113.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat